- NCEs &APIs: Successfully executed about Forty (40) NCEs projects & development of Eight (8) APIs in record time for global innovator and generic Pharma companies.
- Lacosamide API (DMF Ref# 26594) successfully approved by USFDA
- Pharma Generic Intermediates: Cost effective & robust process development for about Ten (10) Pharma Generic Intermediates from bench scale to multi-kilo scale for various MNC’s.
- Indian patent office approved Lacosamide API process patent (Ref: 5149/CHE/2014)
- Strategic Research Partner (SRP): Became SRP for many of the top Indian Pharma companies.